Γρήγορη δράση που διαρκεί!

Βιβλιογραφία

Βιβλιογραφία

  • B.Pelster. Determination of Etofenamate tissue concentration in the knee and clinical relevance of the achieve levels. Topics in arthritis and rheumatism. Volume 2. Edited by B. Pelster. Lippincott-Raven Publisher. Philadelphia 1995.
  • Dell HD. Pharmakokinetic der perkutanen therapie. Separatdruck ausSWISS MED II (1989) Nr12, 12.20.
  • H.D.Dell et al. Biochemistry and pharmacokinetics of Etofenamate studies in man. Arzneim.-Forsch./Drug Res. 27 (I), 6b,1322-1325 (1977)
  • H.Rechziegler. Perkutane Therapie mit nicht-steroidalen Antiphlogistika. Therapiewoche 36, 4674-4683 (1986)
  • B.Pelster. How does etofenamate affect inflammation? The new way: Topical use of non-steroidal anti-inflammatory drugs. 4th International Symposion on Etofenamate. June 18th-21st, 1987, Stresa/Italy.
  • MEDA Company Core Data Sheet. Version 01. June 19, 2012.
  • I.Heindl et al. Clinical trial of the new, percutaneously effective antirheumatic agent etofenamate. Summarising report. Arzneim.-Forsch./Drug Res.27 (I), 6b, 1357-1363 (1977)
  • Περίληψη Χαρακτηριστικών του Προϊόντος.
  • B.Pelster. Osteoarthritis of the knee: percutaneous vs. oral treatment. Topics Arthritis Reumat 1995;2:912
  • W.Blumberger and H.J.Tepe. Saving of oral antirheumatics by local use of etofenamate gel. Therapiewoche 30, 4949-4951 (1980).